Immunotherapy & Oncology
Cancer treatment has moved from poisoning dividing cells towards directing the immune system at the tumour, and towards drugs that carry their payload only to cancerous tissue. It absorbs more drug development spending than any other area.
388 stocks
| # | Name | Holding | Trade Value |
Theme Stocks |
% of Portfolio | Status | |
|---|---|---|---|---|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
| $175B | +$2.34B | 214 | 3.14% | Increased |
|
| 2 |
BlackRock
New York
| $155B | +$1.42B | 238 | 3.25% | Increased |
|
| 3 |
State Street
Boston,
Massachusetts
| $90.5B | +$1.07B | 207 | 3.68% | Increased |
|
| 4 |
Fidelity Investments
Boston,
Massachusetts
| $42.8B | +$2.83B | 172 | 2.6% | Increased |
|
| 5 |
Geode Capital Management
Boston,
Massachusetts
| $40.6B | +$482M | 256 | 3.28% | Increased |
|
| 6 |
JP Morgan Chase
New York
| $36B | -$444M | 218 | 2.74% | Reduced |
|
| 7 |
Morgan Stanley
New York
| $35.6B | +$820M | 263 | 2.58% | Increased |
|
| 8 |
Wellington Management Group
Boston,
Massachusetts
| $29.6B | +$547M | 88 | 5.19% | Increased |
|
| 9 |
T. Rowe Price Associates
Baltimore,
Maryland
| $23.7B | +$752M | 128 | 2.73% | Increased |
|
| 10 |
Norges Bank
Oslo,
Norway
| $23.1B | +$284M | 43 | 3.23% | Increased |
|
| 11 |
Charles Schwab
San Francisco,
California
| $22.9B | +$549M | 139 | 4.37% | Increased |
|
| 12 |
Bank of America
Charlotte,
North Carolina
| $22.5B | +$818M | 256 | 1.8% | Increased |
|
| 13 |
Capital International Investors
Los Angeles,
California
| $22.2B | -$878M | 17 | 4.27% | Reduced |
|
| 14 |
Northern Trust
Chicago,
Illinois
| $19.8B | -$581M | 198 | 3.23% | Reduced |
|
| 15 |
Capital World Investors
Los Angeles,
California
| $19.4B | -$376M | 14 | 3.01% | Reduced |
|
| 16 |
Bank of New York Mellon
New York
| $15.9B | -$460M | 136 | 2.95% | Reduced |
|
| 17 |
Capital Research Global Investors
Los Angeles,
California
| $14.8B | +$201M | 13 | 3.07% | Increased |
|
| 18 |
Franklin Resources
San Mateo,
California
| $13.7B | -$113M | 79 | 3.86% | Reduced |
|
| 19 |
Goldman Sachs
New York
| $13.5B | +$171M | 159 | 2.18% | Increased |
|
| 20 |
Primecap Management
Pasadena,
California
| $13.1B | -$134M | 19 | 9.61% | Reduced |
|
| 21 |
Legal & General Group
London,
United Kingdom
| $13B | +$148M | 128 | 3.42% | Increased |
|
| 22 |
UBS AM
Chicago,
Illinois
| $12.7B | +$124M | 77 | 3.25% | Increased |
|
| 23 |
Invesco
Atlanta,
Georgia
| $12.5B | +$798M | 114 | 2.4% | Increased |
|
| 24 |
Dimensional Fund Advisors
Austin,
Texas
| $11.8B | +$466M | 124 | 2.87% | Increased |
|
| 25 |
Ameriprise
Minneapolis,
Minnesota
| $11.5B | +$204M | 81 | 2.94% | Increased |
|